IL1B and subarachnoid hemorrhage: In a model of subarachnoid hemorrhage in rats, a very recent study found that AE1-329, an EP4 receptor agonist, significantly reduced BBB damage, edema, and expression of IL-1β, IL-6, and TNF-α (Xu et al., 2017).